Navigation Links
New Report Examines Pharmaceutical Sales Force Effectiveness
Date:7/6/2008

- Eularis Challenges Pharma Industry: Are You Measuring the Wrong Things? -

LONDON and TOKYO, July 6 /PRNewswire/ -- With the ever-increasing pressure to ensure maximum return on investment, sales force effectiveness is becoming a high priority in the global pharmaceutical industry. Reports have shown that while sales forces represent the largest spend in pharma sales and marketing, return on this investment has declined sharply in recent years. To address this alarming issue, Eularis announces today the availability of its new report, "Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?"

Written for CEOs, marketing executives and sales executives, this comprehensive research project examines market data and case studies and reports the startling discovery that the very metrics currently being used to assess sales force effectiveness are in fact the ones causing its decline. Focusing on the pharmaceutical industries in the United States, Europe and Japan, the report dissects these current metrics and their limitations, and then offers updated metrics that can help solve the declining effectiveness crisis.

"A pharmaceutical organization's spending on sales force is second only to research and development. Better metrics must be used to measure both the effectiveness and financial impact of this very significant budget element because the current measurements used by most top pharma today actually contribute to the decline in effectiveness of the field force," commented the author of the report, Dr. Andree K. Bates, president of Eularis.

Traditional pharmaceutical organizations are rigorously tracking and managing sales activity, but still falling short. Data emerging from the research concludes that current metrics are more focused on efficiencies rather than effectiveness -- and do so to their own detriment.
The report also identifies core issues at play in SFE, such as:

-- Why sales call frequency metrics are deeply flawed

-- What impact the marketing message has on the customer during the detail

-- Which SFE issues vary by region

-- How to target the right audiences

-- How to incorporate appropriate influencing behaviors into SFE programs

The report discusses appropriate tactics to solve these problems, and demonstrates implementation methods and issues. Sales force effectiveness is a difficult concept to measure, but doing so can push pharmaceutical companies past today's hurdles and into increased productivity and sales.

"Implementing new sales force effectiveness metrics that actually improve effectiveness, and navigating the tricky paths of assessment, changing behaviors, and incorporating eDetailing and CRM systems can be challenging, but it doesn't have to be if you're measuring the right things. Cutting-edge pharmaceutical marketers are turning to appropriate analytics to play an important role in ensuring change is on the right path," closed Bates.

Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. In addition to this and other must-have reports for pharmaceutical industry marketers, she has authored many articles in peer-reviewed journals and several chapters in books on pharmaceutical analytics.

To purchase the Eularis report, "Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?" visit: http://www.pharmaindustrysfe.com/ or http://www.eularis.com/japanese/marketing-excellence/market-reports.asp

About Eularis

Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches which are lengthy and whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling (both professional and consumer), portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Co-headquartered in London and New York City, the company has developed significant experience in the global pharmaceutical market through client engagements globally (including Japan and Asia Pacific) with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others. For more information about Eularis, visit http://www.eularis.com.

*(LOGO LINK: Send2Press.com/mediaboom/08-0630-Eularis_72dpi.jpg)

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Eularis
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia Tech Report Has National Importance
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4. Haemacure Reports Third Quarter 2007 Results
5. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6. Biotech Finishes on a High in August, Burrill Report Says
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. First New York/New Jersey Health Care Report Card Released
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2020)... ... February 14, 2020 , ... ... partnered with Baptist Easley Hospital , a member of Prisma Health, providing ... With PCPLUS, the world-class hospital was able to cut its monthly laundry management ...
(Date:2/14/2020)... ... February 14, 2020 , ... ScripHessco ... Care During Pregnancy. The guide breaks down the benefits of chiropractic care during ... chiropractic care during pregnancy is quite beneficial to the mother’s health. Seeing a ...
(Date:2/14/2020)... ... 14, 2020 , ... “The American Society for Dermatologic Surgery ... discoloration, and lines and wrinkles. And the treatments they are most interested in ... in February specifically to address the areas our patients are most concerned about,” ...
(Date:2/13/2020)... Va. (PRWEB) , ... February 13, 2020 , ... ... with seven locations in Northern Virginia: Arlington, Dulles-Aldie, Fair Oaks, Fairfax, Fredericksburg, Leesburg, ... announce that eight D.C.- and Virginia-based fertility specialists have been named as Top ...
(Date:2/11/2020)... ... February 11, 2020 , ... There are many reasons why Care ... the service that truly raises us above our competitors is our true Peer to ... board-certified Radiologist with years of clinical experience. We understand that it is impossible to ...
Breaking Medicine News(10 mins):
(Date:2/21/2020)... ... February 21, 2020 , ... The business of healthcare management is complex. ... industry trends and ensuring patients digital and physical safety, there are many things to ... That’s why MaintenX International’s is excited to provide their insights on healthcare facility maintenance ...
(Date:2/20/2020)... Calif. (PRWEB) , ... February 20, 2020 , ... ... focused on addressing unmet needs in the field of urology, today announced that ... UroLift® Center of Excellence. The designation recognizes that Dr. Uberoi has achieved a ...
(Date:2/19/2020)... , ... February 19, 2020 , ... Aspire Regenerative, a ... partners with Cortex Wellness Pharmacy for a free weight-loss event on March 1, 2020. ... Girard Ave., #100, La Jolla, CA, 92037. , During the event, physicians and pharmacists ...
Breaking Medicine Technology: